Basket

0538203 - ÚOCHB 2021 US eng A - Abstract
Hollinger, K. R. - Bell, B. J. - Šála, Michal - Dash, R. P. - Thomas, A. G. - Chaudhuri, A. - Kumar, A. - Lovell, L. - Wu, Y. - Rais, R. - Haughey, N. J. - Nencka, Radim - Rojas, C. - Slusher, B. S.
Development of a Neutral Sphingomyelinase 2 Inhibitor for the Treatment of Alzheimer's Disease.
Neurotherapeutics. Springer. Roč. 17, č. 3 (2020), s. 1313-1314. ISSN 1933-7213. E-ISSN 1878-7479.
[ASENT 2020 Annual Meeting /22./. 02.03.2020-05.03.2020, Bethesda]
Institutional support: RVO:61388963
Keywords : Alzheimer * neutral sphingomyelinase 2 * PDDC
OECD category: Organic chemistry
Permanent Link: http://hdl.handle.net/11104/0316304